Clinical Trial Update: Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and preliminary efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) using mitomycin as a single agent in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Carcinomatosis

Drugs mentioned

• Mitomycin (Mitomycin)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Peritoneal Carcinomatosis | Phase 1 | Status: NOT_YET_RECRUITING